|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Medicine and Therapeutics (Drs. Hui and Sung), Microbiology (Drs. Ip, P.K.S. Chan, and Tang), and Anesthesia and Intensive Care (Dr. M.T.V. Chan), and the Centre for Emerging Infectious Diseases (Ms. Wong), The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, Peoples Republic of China; and the School of Mechanical Engineering (Dr. Hall), University of New South Wales, Sydney, NSW, Australia.
Correspondence to: Julian W. Tang, MBChB, PhD, Department of Microbiology, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, Peoples Republic of China; e-mail: julian.tang{at}cuhk.edu.hk
Abstract
Patients with respiratory infections often require the use of supplemental oxygen via oxygen masks, which, in the hospital, may become sources of aerosolized infectious pathogens. To assess this risk, a human lung model (respiration rate, 12 breaths/min) was designed to test the potential for a simple oxygen mask at a common setting (4 L/min) to disperse potentially infectious exhaled air into the surrounding area. A laser sheet was used to illuminate the exhaled air from the mask, which contained fine tracer smoke particles. An analysis of captured digital images showed that the exhaled air at the peak of simulated exhalation reached a distance of approximately 0.40 m.
Key Words: aerosol airborne airflow hospital-acquired infection infection control nosocomial oxygen mask transmission visualization
Patients admitted to the hospital with pneumonia often require supplemental oxygen via nasal cannula or oronasal masks. Usually, there are no additional isolation precautions taken for such patients, and they may be on an open ward with a respiratory infection, breathing with the aid of an oxygen mask that is supplying oxygen at a flow rate of up to 10 L/min. However, little is known about the airflow characteristics of such oxygen delivery devices and their ability to transmit infection by aerosol. This problem of hospital-acquired infection via infectious aerosol was highlighted in the severe acute respiratory syndrome (SARS) epidemics of 2003.1 Many cases of SARS occurred within hospitals with infections taking place between patients and health-care workers, in some cases apparently assisted by oxygen delivery and other respiratory support devices.1 Since then, it has been reported that SARS-coronavirus (CoV) RNA can be detected in air,2 and in some cases airborne SARS CoV can also be grown in culture, demonstrating viability.3 More recently, avian influenza (influenza H5N1) has led to a high mortality rate in human cases in Thailand and Vietnam.45 The strongest case implicating person-to-person transmission of influenza H5N1 also occurred in a hospital setting.6 The potential for long-range, airborne transmission for both influenza67 and SARS CoV8 has been reported. Yet, it has been difficult to demonstrate the risk of aerosol transmission of such respiratory infections in the health-care environment, and there are still many serious gaps in our knowledge.7
In one study, using aerosolized 3% hypertonic saline solution and photographic techniques, Somogyi et al9 demonstrated that throughout exhalation, both the nonrebreathing and Venturi-type oxygen masks channeled the exhaled gas through side vents, forming a leakage plume of exhaled gas that was directed to either side of the patient. The authors asked the volunteer to hold his breath for approximately 2 s, while the masks were fitted to his face. The volunteer then exhaled smoothly for at least 2 s, during which a series of still photographs were taken. Although the volunteers breathing action was not physiologic in this study, the authors demonstrated that such oxygen masks could produce potentially infectious plumes from exhaled air that could be inhaled by health-care workers, visitors, and other patients.
In order to further assess the potential for oxygen masks to spread infection, we designed a human lung model with a more realistic breathing cycle. In addition, we applied an engineering-based approach to visualize and analyze the airflow images recorded on digital video during simulated respiration with a simple oxygen mask.
Materials and Methods
Human Lung Model
A high-fidelity human patient simulator (HPS) [model 6.1; Medical Education Technologies Inc; Sarasota, FL], representing a medium-sized adult man sitting on a 45°-inclined hospital bed, was fitted with a simple oxygen mask (HS-3031; Hsiner; Taichung Hsien, Taiwan). The head, neck, and internal airways of the HPS were configured to allow realistic airflow modeling in the airways and around the face. Oxygen flow was set as 4 L/min, and the simulator was programmed for a respiratory rate of 12 breaths/min and a tidal volume of 0.5 L.
Imaging and Video Capture System
The mask airflow was visualized by smoke using an M-6000 smoke generator (model N19; DS Electronics; Tempe, AZ). The generated smoke was continuously introduced to the right main bronchus of the HPS as part of the inhaled air. This design allowed the smoke to continuously mix with the alveolar gas and then to be part of the exhaled air, to allow visualization.
Initially, the smoke airflow was illuminated with a strong halogen light to reveal the full three-dimensional extent of the mask airflow and the leakage plume. Sections through the plume were then revealed by an intense laser light-sheet created by an Nd:YVO4 Q-switched, frequency-doubled laser (OEM T20-BL 10106Q; Spectra-Physics Lasers; Mountain View, CA), with custom cylindrical optics for two-dimensional laser light-sheet generation (Fig 1 ). This was recorded with a three charge-couple device, x48 zoom digital video system (Sony; Tokyo, Japan) at an image rate of 30 Hz.
|
Following the positioning of the laser light-sheet, the video images captured were synchronized with the respiratory cycle by starting the video capture at the exact beginning of breath exhalation. The video recording captured many simulated breath cycles, and the images corresponding to the maximum expired volume during each respiratory cycle were analyzed. Both real-time full-motion video (30 images per second) and snapshot images of the video images were analyzed.
Video Image Analysis
Full-motion video was reviewed in real-time using a movie editor (Windows Movie Maker; Microsoft; Richmond, WA), and the best images of respiration showing airflow behavior were analyzed using software that was developed for this study (Matlab 6.5). In order to obtain the clearest boundary of dissemination, image-processing techniques were applied to these images to define the edge of the visible smoke boundary from the captured digital video images (see supplementary material at www.chestnet.org). These techniques were applied to a selected video image that represented the peak of simulated exhalation during one breath cycle by the human simulator. Finally, we assumed that the smoke propagations were symmetric under the symmetric mask structure. This was observed and confirmed during the initial three-dimensional flow visualization using the halogen light. Hence, a symmetric image was constructed (Fig 2
).
|
The final maximum distance traveled by the exhaled smoke plume, using this simple oxygen mask (HS-3031; Hsiner) with an oxygen flow of 4 L/min, a respiratory rate of 12 breaths/min, and a tidal volume of 0.5 L, was approximately 0.40 m (Fig 2). It was finally decided to choose the video image/footage of the most clearly illuminated smoke plume, demonstrating the maximum distance traveled at the peak of exhalation for image analysis. The reason for this was one of safety. Such a maximum distance will give added safety if it is used as a guide to the safe distance required for the prevention of hospital-acquired aerosol transmission infections. This distance was defined on the basis of the image analysis technique that was used to smooth and approximate the boundary of the visible smoke on video that had been recorded by the digital camera. The defined boundary of the smoke was based on the reflected light intensity of the smoke particles when illuminated by the laser sheet (see supplementary material for further details).
Discussion
The HPS has been used in medical training, especially in anesthesia, emergency, and critical care medicine. It is also a realistic representation of human respiratory physiology. The HPS contains a realistic airway and a lung model that undergoes gas exchange (ie, it consumes oxygen and produces carbon dioxide). The lung compliance and airway resistance respond in a realistic manner to relevant challenges. It also produces an airflow pattern that is close to the in vivo human situation. A report on the use of an HPS to study complex respiratory physiology has been published previously.1011121314
There have been a few studies about the production of aerosols from the use of oxygen masks. However, although their methodology was quite different, a useful comparison can still be made with the study by Somogyi et al,9 who produced images of exhaled airflows using three different oxygen masks on a human volunteer. Their study is not directly comparable to this one mainly because the oxygen masks they used had no oxygen flow supplied. Only the volunteers natural exhalation after brief breath holding produced the air movement. This is not a natural breathing cycle, and, in this respect, the cyclical respiration pattern in the human lung model presented here may be more realistic. Although Somogyi et al9 showed images of the behavior of the exhaled air plume, they did not report quantitative data, such as the distance traveled by the visible air plumes shown in their images. However, a closer inspection of their Figure 1A, which illustrates a side plume of exhaled air emitted from a simple nonrebreathing oxygen mask, appears to show that it extends approximately two head diameters away from the mask. The head diameter of an adult has been reported to be approximately 13 to 16 cm.15 Thus, the extent of the visible plume shown in their Figure 1A can be estimated to be approximately 0.30 m. Furthermore, these authors stated the following: "The spread of the exhaled gas may be greater than shown, as evaporation and reduction in density of the droplets at the margin of the plume may limit their effectiveness as markers." Although the methodology and human lung model parameters used in this study may have been somewhat different (oxygen flow, 4 L/min; respiratory rate, 12 breaths/min; tidal volume, 0.5 L), the distance traveled (0.40 m) by the exhaled smoke plume in this study seems remarkably similar.
There are some limitations that are specific to this study. Most significantly, fine smoke particles rather than droplets were used in this study. This smoke consists of submicrometer m particles that will follow the path of the air flow precisely.1617 Thus, the extent of spread of the smoke is representative of the airflow around the mask. This distance is derived from smoke particles that are visible enough to be analyzed from the digitally captured video images. This will almost certainly be a lower limit approximation as there will be smoke particles traveling beyond the visible boundaries seen in these images. These particles cannot be visualized effectively because there are too few at these distances to scatter sufficient light to be easily detected on the video images.
Second, it has been estimated that droplets generated from the upper respiratory tract by, for instance, coughing, sneezing, talking, singing, and breathing, range from 0.5 to 12 µm in diameter.18 As viral and bacterial agents range from approximately 0.020 to 100 µm in size, the size of the exhaled droplet will obviously limit the number of such infectious agents that can be carried in each droplet. The majority of naturally produced aerosol droplets are much larger than the smoke particles used in this study. Therefore, most of them will not follow the exhaled airflow perfectly, but will move relatively more slowly horizontally due to their larger size and will fall more quickly under the effects of gravity19 and thus not travel as far as the smoke particles used in this study. However, some of the smaller droplets exhaled by a human patient may be reduced in size sufficiently by evaporation within the exhaled, oxygen-assisted airflow and remain suspended in air for considerable periods of time. These smaller particles may then more closely be represented by the smoke particles used in this study. Therefore, the boundaries of the smoke cloud indicated in Figure 2 are likely to represent an upper boundary of the distance traveled by real infectious droplets and may therefore be taken as defining a zone of potential aerosol infection with an extra margin of safety.
There is no reliable and safe marker that can be introduced into human lungs for study. The use of the human lung model here allows for only one set of parameters to be tested at one time. So, while a healthy human patient would sometimes be breathing quietly, then sometimes talking, coughing, or sneezing (when the mask may be removed), the behavior of this human lung model is unchanging. However, this study allows a baseline estimate of the distance traveled by any potentially infectious aerosols, while the patient is at rest.
Conclusion
This study effectively complements that of Somogyi et al9 and demonstrates that patients with transmissible respiratory infections such as influenza H5N1 and SARS, who are breathing with the aid of oxygen masks, may be a potential source of aerosol-transmitted infection. These patients should, ideally, be managed in a single, isolation room, under negative pressure, though with their relatively high cost, not all health-care institutions may possess such facilities. During the SARS epidemics of 2003, health-care workers managing SARS patients found that they could protect themselves by the effective and consistent use of personal protective equipment,20 and that the converse was also true.21 Influenza H5N1 is likely to be a more infectious, transmissible pathogen,22 so effective, well-informed infection control precautions will be even more important to prevent hospital-acquired infections in both health-care workers and patients.
Footnotes
Abbreviations: CoV = coronavirus; HPS = human patient simulator; SARS = severe acute respiratory syndrome
This project was supported by the Research Fund for the Control of Infectious Diseases from the Health, Welfare and Food Bureau of the Hong Kong Special Administrative Region Government.
The authors have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.
Received for publication December 1, 2005. Accepted for publication February 22, 2006.
References
Related Article
This article has been cited by other articles:
![]() |
D. S. Hui, S. D. Hall, M. T.V. Chan, B. K. Chow, S. S. Ng, T. Gin, and J. J.Y. Sung Exhaled Air Dispersion During Oxygen Delivery Via a Simple Oxygen Mask Chest, August 1, 2007; 132(2): 540 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fisher, D. S. Hui, and J. W-T. Tang Oxygen Administration and the Protection of Health-Care Workers From Infections Chest, March 1, 2007; 131(3): 941 - 942. [Full Text] [PDF] |
||||
![]() |
D. S. Hui, S. D. Hall, M. T.V. Chan, B. K. Chow, J. Y. Tsou, G. M. Joynt, C. E. Sullivan, and J. J.Y. Sung Noninvasive positive-pressure ventilation: an experimental model to assess air and particle dispersion. Chest, September 1, 2006; 130(3): 730 - 740. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |